QNCX
Quince Therapeutics, Inc.
Price Chart
Latest Quote
$0.95
+0.04 (+4.66%)
Current Price
| Previous Close | $0.90 |
| Open | $0.90 |
| Day High | $1.00 |
| Day Low | $0.89 |
| Volume | 736,595 |
Stock Information
| Shares Outstanding | 19.56M |
| Total Debt | $406K |
| Cash Equivalents | $18.16M |
| Net Income | $-36.16M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $18.49M |
| EPS (TTM) | $-10.80 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-2.35M |
| Income | $-36.16M |
| Book/sh | $1.14 |
| Cash/sh | $0.93 |
| Employees | 38 |
Financial Ratios
| Quick Ratio | 2.82 |
| Current Ratio | 2.92 |
| Debt/Eq | 2.59 |
Returns & Margins
| ROA | -45.44% |
| ROE | -192.90% |
Ownership
| Insider Ownership | 3.19% |
| Institutional Ownership | 17.06% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.81 |
| P/B | 0.83 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.03 |
| SMA50 | $1.17 |
| SMA200 | $13.04 |
| RSI | 29.86 |
| ATR | 0.0750 |
| Shares Float | 14.30M |
| Short Float | 10.56% |
| Short Ratio | 1.04 |
| Volatility | 1.37 |
| Rel Volume | 1.02 |
Performance History
| Week | -0.21% |
| Month | -11.68% |
| Quarter | +7.39% |
| 6 Months | -97.45% |
| YTD | -96.85% |
| Year | -93.05% |
| 3 Years | -94.02% |
| 5 Years | -99.81% |
| 10 Years | -99.71% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.94 | 736,600 |
| 2026-06-17 | $0.90 | 290,400 |
| 2026-06-16 | $0.90 | 182,300 |
| 2026-06-15 | $0.93 | 215,400 |
| 2026-06-12 | $0.93 | 350,200 |
| 2026-06-11 | $0.95 | 373,700 |
| 2026-06-10 | $0.91 | 325,200 |
| 2026-06-09 | $0.97 | 811,700 |
| 2026-06-08 | $1.00 | 247,300 |
| 2026-06-05 | $1.01 | 797,800 |
| 2026-06-04 | $1.10 | 1,036,800 |
| 2026-06-03 | $1.03 | 1,111,000 |
| 2026-06-02 | $1.05 | 638,900 |
| 2026-06-01 | $1.11 | 737,900 |
| 2026-05-29 | $1.15 | 710,600 |
| 2026-05-28 | $1.17 | 680,500 |
| 2026-05-27 | $1.15 | 981,800 |
| 2026-05-26 | $1.20 | 1,795,800 |
| 2026-05-22 | $1.10 | 1,223,300 |
| 2026-05-21 | $1.07 | 1,204,800 |
| 2026-05-20 | $1.08 | 1,267,200 |
| 2026-05-19 | $1.07 | 1,834,800 |
About Quince Therapeutics, Inc.
Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises eDSP, which is in Phase 3, for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells, as well as consist of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising kit medical devices, syringe kit, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
đ° Latest News
Quince Therapeutics Inc. (QNCX) Presents Positive Phase 2a Data for LAM-001 Inhaled Therapy
Insider Monkey âĸ 2026-06-02T13:56:48Z
BC-Most Active Stocks
Associated Press Finance âĸ 2026-03-05T15:30:17ZQuince Therapeuticsâ stock crashes on Phase III ataxia-telangiectasia failure
Clinical Trials Arena âĸ 2026-02-02T12:19:55Z
Spotify upgraded, Pinterest downgraded: Wall Street's top analyst calls
The Fly âĸ 2026-01-30T14:54:01Z
Quince Therapeutics price target raised to $5 from $4 at D. Boral Capital
TipRanks âĸ 2025-12-16T14:26:14Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $50,429,000 | $36,170,000 | $27,142,000 | $51,190,000 |
| Other Income Expense | $-31,580,000 | $-23,500,000 | $-7,918,000 | $-1,822,000 |
| Other Non Operating Income Expenses | $-1,557,000 | $-2,385,000 | $-440,000 | $-997,000 |
| Net Non Operating Interest Income Expense | $1,244,000 | $2,929,000 | $3,478,000 | $1,068,000 |
| Operating Expense | $50,429,000 | $36,170,000 | $27,142,000 | $51,190,000 |
| General And Administrative Expense | $15,047,000 | $17,580,000 | $17,695,000 | $26,012,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-83,979,000 | $-56,828,000 | $-31,385,000 | $-51,660,000 |
| Net Interest Income | $1,244,000 | $2,929,000 | $3,478,000 | $1,068,000 |
| Interest Income | $1,244,000 | $2,929,000 | $3,478,000 | $1,068,000 |
| Normalized Income | $-60,260,830 | $-40,147,150 | $-23,953,364 | $-50,839,538 |
| Net Income From Continuing And Discontinued Operation | $-83,979,000 | $-56,828,000 | $-31,385,000 | $-51,660,000 |
| Total Operating Income As Reported | $-58,068,000 | $-57,285,000 | $-34,620,000 | $-52,015,000 |
| Net Income Common Stockholders | $-83,979,000 | $-56,828,000 | $-31,385,000 | $-51,660,000 |
| Net Income | $-83,979,000 | $-56,828,000 | $-31,385,000 | $-51,660,000 |
| Net Income Including Noncontrolling Interests | $-83,979,000 | $-56,828,000 | $-31,385,000 | $-51,660,000 |
| Net Income Continuous Operations | $-83,979,000 | $-56,828,000 | $-31,385,000 | $-51,660,000 |
| Pretax Income | $-80,765,000 | $-56,741,000 | $-31,582,000 | $-51,944,000 |
| Special Income Charges | $-7,639,000 | $-21,115,000 | $-7,478,000 | $-825,000 |
| Interest Income Non Operating | $1,244,000 | $2,929,000 | $3,478,000 | $1,068,000 |
| Operating Income | $-50,429,000 | $-36,170,000 | $-27,142,000 | $-51,190,000 |
| Per Share | ||||
| Diluted EPS | $-16.80 | $-13.10 | $-8.40 | $-15.40 |
| Basic EPS | $-16.80 | $-13.10 | $-8.40 | $-15.40 |
| Other | ||||
| Tax Effect Of Unusual Items | $-6,304,830 | $-4,434,150 | $-46,364 | $-4,538 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-20,264,000 | $-14,869,000 | $-19,342,000 | $-50,161,000 |
| Total Unusual Items | $-30,023,000 | $-21,115,000 | $-7,478,000 | $-825,000 |
| Total Unusual Items Excluding Goodwill | $-30,023,000 | $-21,115,000 | $-7,478,000 | $-825,000 |
| Reconciled Depreciation | $142,000 | $186,000 | $322,000 | $204,000 |
| EBITDA (Bullshit earnings) | $-50,287,000 | $-35,984,000 | $-26,820,000 | $-50,986,000 |
| EBIT | $-50,429,000 | $-36,170,000 | $-27,142,000 | $-51,190,000 |
| Diluted Average Shares | $5,009,689 | $4,326,226 | $3,723,714 | $3,349,653 |
| Basic Average Shares | $5,009,689 | $4,326,226 | $3,723,714 | $3,349,653 |
| Diluted NI Availto Com Stockholders | $-83,979,000 | $-56,828,000 | $-31,385,000 | $-51,660,000 |
| Tax Provision | $3,214,000 | $87,000 | $-197,000 | $-284,000 |
| Impairment Of Capital Assets | $0 | $17,130,000 | $5,900,000 | $825,000 |
| Restructuring And Mergern Acquisition | $7,639,000 | $3,985,000 | $1,578,000 | $0 |
| Gain On Sale Of Security | $-22,384,000 | - | - | - |
| Research And Development | $35,382,000 | $18,590,000 | $9,447,000 | $25,178,000 |
| Selling General And Administration | $15,047,000 | $17,580,000 | $17,695,000 | $26,012,000 |
| Other Gand A | $15,047,000 | $17,580,000 | $17,695,000 | $26,012,000 |
Fetched: 2026-06-19
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-103,533,000 | $-29,899,000 | $3,787,000 | $94,693,000 |
| Total Assets | $93,523,000 | $114,478,000 | $167,900,000 | $103,910,000 |
| Total Non Current Assets | $70,627,000 | $70,442,000 | $90,460,000 | $10,162,000 |
| Non Current Accounts Receivable | $1,682,000 | $9,506,000 | $8,456,000 | - |
| Investmentin Financial Assets | $78,000 | $78,000 | $78,000 | $3,578,000 |
| Goodwill And Other Intangible Assets | $67,819,000 | $60,045,000 | $81,297,000 | $5,900,000 |
| Other Intangible Assets | $67,819,000 | $60,045,000 | $63,672,000 | $5,900,000 |
| Current Assets | $22,896,000 | $44,036,000 | $77,440,000 | $93,748,000 |
| Other Current Assets | $54,000 | $84,000 | $81,000 | $276,000 |
| Prepaid Assets | $1,468,000 | $2,286,000 | $1,307,000 | $2,288,000 |
| Receivables | $3,622,000 | $882,000 | $993,000 | $1,003,000 |
| Taxes Receivable | $3,622,000 | $882,000 | $993,000 | $1,003,000 |
| Cash Cash Equivalents And Short Term Investments | $17,752,000 | $40,784,000 | $75,059,000 | $90,181,000 |
| Cash And Cash Equivalents | $5,809,000 | $6,212,000 | $20,752,000 | $44,579,000 |
| Cash Equivalents | $4,402,000 | $3,702,000 | $19,231,000 | $40,593,000 |
| Cash Financial | $1,407,000 | $2,510,000 | $1,521,000 | $3,986,000 |
| Other Non Current Assets | - | - | $10,000 | - |
| Debt | ||||
| Net Debt | $12,217,000 | $8,109,000 | - | - |
| Total Debt | $18,471,000 | $14,811,000 | $13,814,000 | $453,000 |
| Long Term Debt And Capital Lease Obligation | $330,000 | $14,715,000 | $13,750,000 | $0 |
| Current Debt And Capital Lease Obligation | $18,141,000 | $96,000 | $64,000 | $453,000 |
| Current Debt | $18,026,000 | - | - | - |
| Other Current Borrowings | $18,026,000 | - | - | - |
| Long Term Debt | - | $14,321,000 | $13,429,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $129,237,000 | $84,332,000 | $82,816,000 | $3,317,000 |
| Total Non Current Liabilities Net Minority Interest | $86,011,000 | $77,054,000 | $73,244,000 | $248,000 |
| Other Non Current Liabilities | $53,531,000 | $57,376,000 | $54,190,000 | - |
| Derivative Product Liabilities | $32,150,000 | $0 | - | - |
| Non Current Deferred Liabilities | $0 | $4,963,000 | $5,304,000 | $248,000 |
| Non Current Deferred Taxes Liabilities | $0 | $4,963,000 | $5,304,000 | $248,000 |
| Current Liabilities | $43,226,000 | $7,278,000 | $9,572,000 | $3,069,000 |
| Other Current Liabilities | $12,577,000 | $308,000 | $4,360,000 | $185,000 |
| Payables And Accrued Expenses | $12,508,000 | $6,874,000 | $5,148,000 | $2,431,000 |
| Payables | $2,223,000 | $2,903,000 | $2,033,000 | $570,000 |
| Accounts Payable | $2,223,000 | $2,903,000 | $2,033,000 | $570,000 |
| Equity | ||||
| Common Stock Equity | $-35,714,000 | $30,146,000 | $85,084,000 | $100,593,000 |
| Total Equity Gross Minority Interest | $-35,714,000 | $30,146,000 | $85,084,000 | $100,593,000 |
| Stockholders Equity | $-35,714,000 | $30,146,000 | $85,084,000 | $100,593,000 |
| Gains Losses Not Affecting Retained Earnings | $5,750,000 | $-35,000 | $3,047,000 | $-289,000 |
| Other Equity Adjustments | $5,750,000 | $-35,000 | $3,047,000 | $-289,000 |
| Retained Earnings | $-460,451,000 | $-376,472,000 | $-319,644,000 | $-288,259,000 |
| Other | ||||
| Ordinary Shares Number | $5,572,529 | $4,400,164 | $4,297,321 | $3,613,648 |
| Share Issued | $5,572,529 | $4,400,164 | $4,297,321 | $3,613,648 |
| Tangible Book Value | $-103,533,000 | $-29,899,000 | $3,787,000 | $94,693,000 |
| Invested Capital | $-17,688,000 | $44,467,000 | $98,513,000 | $100,593,000 |
| Working Capital | $-20,330,000 | $36,758,000 | $67,868,000 | $90,679,000 |
| Capital Lease Obligations | $445,000 | $490,000 | $385,000 | $453,000 |
| Total Capitalization | $-35,714,000 | $44,467,000 | $98,513,000 | $100,593,000 |
| Additional Paid In Capital | $418,932,000 | $406,609,000 | $401,638,000 | $389,105,000 |
| Capital Stock | $55,000 | $44,000 | $43,000 | $36,000 |
| Common Stock | $55,000 | $44,000 | $43,000 | $36,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $330,000 | $394,000 | $321,000 | $0 |
| Current Capital Lease Obligation | $115,000 | $96,000 | $64,000 | $453,000 |
| Current Accrued Expenses | $10,285,000 | $3,971,000 | $3,115,000 | $1,861,000 |
| Investments And Advances | $78,000 | $78,000 | $78,000 | $3,578,000 |
| Available For Sale Securities | $78,000 | $78,000 | $78,000 | $3,578,000 |
| Net PPE | $1,048,000 | $813,000 | $619,000 | $684,000 |
| Accumulated Depreciation | $-844,000 | $-639,000 | $-507,000 | $-185,000 |
| Gross PPE | $1,892,000 | $1,452,000 | $1,126,000 | $869,000 |
| Leases | $38,000 | $34,000 | $36,000 | $21,000 |
| Other Properties | $1,529,000 | $1,133,000 | $871,000 | $830,000 |
| Machinery Furniture Equipment | $325,000 | $285,000 | $219,000 | $18,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $11,943,000 | $34,572,000 | $54,307,000 | $45,602,000 |
| Goodwill | - | $0 | $17,625,000 | $0 |
| Non Current Accrued Expenses | - | - | $53,603,000 | $0 |
Fetched: 2026-06-19
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-41,777,000 | $-32,161,000 | $-18,452,000 | $-44,171,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-41,425,000 | $-31,904,000 | $-18,292,000 | $-44,038,000 |
| Cash Flow From Continuing Operating Activities | $-41,425,000 | $-31,904,000 | $-18,292,000 | $-44,038,000 |
| Operating Gains Losses | $21,470,000 | - | $-41,000 | $94,000 |
| Investing Activities | ||||
| Capital Expenditure | $-352,000 | $-257,000 | $-160,000 | $-133,000 |
| Investing Cash Flow | $23,227,000 | $21,908,000 | $-5,758,000 | $18,002,000 |
| Cash Flow From Continuing Investing Activities | $23,227,000 | $21,908,000 | $-5,758,000 | $18,002,000 |
| Net Other Investing Changes | - | - | $-910,000 | $70,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $17,689,000 | $0 | $0 | $608,000 |
| Financing Cash Flow | $17,909,000 | $-4,775,000 | $143,000 | $707,000 |
| Cash Flow From Continuing Financing Activities | $17,909,000 | $-4,775,000 | $143,000 | $707,000 |
| Net Common Stock Issuance | $17,689,000 | $0 | $0 | $608,000 |
| Common Stock Issuance | $17,689,000 | $0 | $0 | $608,000 |
| Net Other Financing Charges | - | $-5,000,000 | - | - |
| Other | ||||
| Interest Paid Supplemental Data | $234,000 | $0 | - | - |
| End Cash Position | $5,809,000 | $6,212,000 | $20,752,000 | $44,579,000 |
| Beginning Cash Position | $6,212,000 | $20,752,000 | $44,579,000 | $69,724,000 |
| Effect Of Exchange Rate Changes | $-114,000 | $231,000 | $80,000 | $184,000 |
| Changes In Cash | $-289,000 | $-14,771,000 | $-23,907,000 | $-25,329,000 |
| Proceeds From Stock Option Exercised | $220,000 | $225,000 | $149,000 | $148,000 |
| Net Investment Purchase And Sale | $23,579,000 | $22,165,000 | $-2,572,000 | $7,472,000 |
| Sale Of Investment | $57,997,000 | $111,727,000 | $111,209,000 | $82,493,000 |
| Purchase Of Investment | $-34,418,000 | $-89,562,000 | $-113,781,000 | $-75,021,000 |
| Net PPE Purchase And Sale | $-352,000 | $-257,000 | $-160,000 | $-133,000 |
| Purchase Of PPE | $-352,000 | $-257,000 | $-160,000 | $-133,000 |
| Change In Working Capital | $12,843,000 | $-484,000 | $1,977,000 | $-9,829,000 |
| Change In Other Current Liabilities | $742,000 | $109,000 | - | - |
| Change In Other Current Assets | $4,308,000 | $-876,000 | $-9,000 | $194,000 |
| Change In Payables And Accrued Expense | $4,836,000 | $1,994,000 | $-2,260,000 | $-12,603,000 |
| Change In Accrued Expense | $5,776,000 | $1,067,000 | $-1,972,000 | $-6,660,000 |
| Change In Payable | $-940,000 | $927,000 | $-288,000 | $-5,943,000 |
| Change In Account Payable | $-940,000 | $927,000 | $-288,000 | $-5,943,000 |
| Change In Prepaid Assets | $2,957,000 | $-1,711,000 | $4,246,000 | $2,580,000 |
| Other Non Cash Items | $8,971,000 | $5,694,000 | $1,668,000 | $-313,000 |
| Stock Based Compensation | $5,105,000 | $4,746,000 | $5,220,000 | $16,618,000 |
| Asset Impairment Charge | $0 | $17,130,000 | $5,966,000 | $961,000 |
| Amortization Of Securities | $-1,014,000 | $-2,348,000 | $-2,019,000 | $-113,000 |
| Deferred Tax | $-4,963,000 | $0 | - | - |
| Deferred Income Tax | $-4,963,000 | $0 | - | - |
| Depreciation Amortization Depletion | $142,000 | $186,000 | $322,000 | $204,000 |
| Depreciation And Amortization | $142,000 | $186,000 | $322,000 | $204,000 |
| Gain Loss On Investment Securities | $21,470,000 | - | - | - |
| Net Income From Continuing Operations | $-83,979,000 | $-56,828,000 | $-31,385,000 | $-51,660,000 |
| Repayment Of Debt | - | $0 | $-6,000 | $-49,000 |
| Net Issuance Payments Of Debt | - | $0 | $-6,000 | $-49,000 |
| Net Long Term Debt Issuance | - | $0 | $-6,000 | $-49,000 |
| Long Term Debt Payments | - | $0 | $-6,000 | $-49,000 |
| Net Business Purchase And Sale | - | $0 | $-2,116,000 | $10,593,000 |
| Purchase Of Business | - | $0 | $-2,116,000 | $0 |
| Change In Other Working Capital | - | $-135,000 | - | - |
| Gain Loss On Sale Of PPE | - | $0 | $-41,000 | $94,000 |
| Sale Of Business | - | - | $0 | $10,593,000 |
Fetched: 2026-06-19